ACCESS Health Consultant’s Bereaved Caregivers Project Receives Seed Funding
ACCESS Health Southeast Asia Consultant Miguel Tan took part in the Design4Impact (D4I) challenge, an open platform inviting innovators to co-create sustainable community-owned solutions supported by the Ministry of Health Office for Healthcare Transformation. This year’s theme was “Uplifting Vulnerable Families in …
Dr. Uma Aysola participates in Harvard Business School Executive Leadership Development Program
ACCESS Health India Director of Communications and Relations, Dr. Uma Aysola, participated in The Rockefeller Foundation’s 2023 Executive Leadership Development Program at Harvard Business School. Dr. Aysola was recommended as an external participant in the week-long program by The Rockefeller Foundation’s Asia Region …
Adapted SynNotch, A New Generation Of Flexible And Controllable CAR T Therapies (Part 3)
This is the final installment in our series on alternate CAR T therapies. Part one describes a version of CAR T which uses a universal adaptor. Part two introduces SNAPtag, an alternative CAR T therapy. Visit the website www.williamhaseltine.com for more on …
How One Man’s Rare Alzheimer’s Mutation Delayed The Onset Of Disease
Neurologists have discovered a genetic mutation that may protect the brain from dementia. Francisco Lopera, a researcher at the University of Antioquia in Colombia, has spent almost forty years studying a family of individuals with a rare form of early-onset Alzheimer’s disease …
SynNotch, A New Generation Of Flexible And Controllable CAR T Therapies (Part 2)
Chimeric Antigen Receptor T cell (CAR T) therapy is a cell-based treatment that has garnered success in treating blood cancers like large B cell lymphoma, leukemia, and multiple myeloma. However, certain limitations prevent the therapy’s adaptation to other diseases. Recent research suggests …
A New Generation Of Flexible And Controllable CAR T Therapies
Chimeric Antigen Receptor T cell (CAR T) therapy is one of the exciting new modalities of cancer treatment. The therapy modifies a patient’s own immune cells to treat specific tumors. This is traditionally accomplished by bioengineering hybrid receptors and attaching them onto …
A New Hope For Osteoarthritis Treatment And Prevention (Part 2)
Osteoarthritis is a common degenerative joint disease that results from aging or injury. Although the swelling, stiffness and pain in the joints can impair daily life or even lead to disability, treatment options are limited. A recent study in Science Advances provides insight …
A New Understanding of Osteoarthritis: Synovial Inflammation Inhibits Cartilage Repair (Part 1)
This is the first of two stories describing recent progress in understanding the cause and potential treatment for osteoarthritis. In part two, we will discuss how this discovery may yield clinical benefits. This story is part of an extensive series on regenerative …
ACCESS Health Undertakes Healthcare Transformation at Lotus Hospitals
Drawing on 15 years of experience in healthcare transformation, ACCESS Health has worked with the Lotus Hospitals Group over the last year to undertake a complete transformation in areas such as market growth, process streamlining, capacity building, quality management, employee productivity, cost …
Efficient Delivery of Social Protection: Leveraging Interoperability with CRVS Systems
Countries around the world implement several Social Protection (SP) programs for their residents to address various situations. Determining the eligibility of potential beneficiaries necessitates information exchange across different social protection information systems and foundational platforms such as Civil Registration and Vital Statistics …
Recent Comments